Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) rose 3.8% on Tuesday . The stock traded as high as GBX 51.90 and last traded at GBX 51.90. Approximately 59,455 shares were traded during mid-day trading, a decline of 18% from the average daily volume of 72,176 shares. The stock had previously closed at GBX 50.
Beximco Pharmaceuticals Price Performance
The company has a 50-day moving average of GBX 42.69 and a 200 day moving average of GBX 42.65. The company has a quick ratio of 0.37, a current ratio of 2.18 and a debt-to-equity ratio of 12.57. The stock has a market capitalization of £231.53 million, a PE ratio of 0.04 and a beta of 0.61.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Recommended Stories
- Five stocks we like better than Beximco Pharmaceuticals
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
